CCDC47 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.891600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.545000E-01
Normal-vs-Stage2
5.088200E-01
Normal-vs-Stage3
8.974800E-01
Normal-vs-Stage4
1.051380E-01
Stage1-vs-Stage2
9.369200E-01
Stage1-vs-Stage3
4.683400E-01
Stage1-vs-Stage4
7.100600E-01
Stage2-vs-Stage3
5.235800E-01
Stage2-vs-Stage4
5.352800E-01
Stage3-vs-Stage4
3.417800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.631000E-01
Normal-vs-AfricanAmerican
2.218800E-01
Normal-vs-Asian
4.926600E-01
Caucasian-vs-AfricanAmerican
2.731800E-01
Caucasian-vs-Asian
6.200800E-01
AfricanAmerican-vs-Asian
3.192800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.898600E-01
Normal-vs-Female
5.110200E-01
Male-vs-Female
2.439200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.338400E-01
Normal-vs-Age(41-60Yrs)
1.166960E-01
Normal-vs-Age(61-80Yrs)
6.135800E-01
Normal-vs-Age(81-100Yrs)
6.926000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.907400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.843200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.768000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.557170E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.552100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.553800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.911200E-01
Normal-vs-Daily Drinker
7.767800E-01
Normal-vs-Weekly Drinker
7.242800E-01
Normal-vs-Occasional Drinker
2.113200E-01
Normal-vs-Social Drinker
1.866380E-01
Non Drinker-vs-Daily Drinker
4.756400E-01
Non Drinker-vs-Weekly Drinker
7.786200E-01
Non Drinker-vs-Occasional Drinker
1.106250E-01
Non Drinker-vs-Social Drinker
2.370200E-01
Daily Drinker-vs-Weekly Drinker
7.642400E-01
Daily Drinker-vs-Occasional Drinker
2.384200E-02
Daily Drinker-vs-Social Drinker
4.726200E-02
Weekly Drinker-vs-Occasional Drinker
1.238440E-01
Weekly Drinker-vs-Social Drinker
1.998030E-01
Occasional Drinker-vs-Social Drinker
6.717400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.215780E-01
Normal-vs-Grade 2
3.053200E-01
Normal-vs-Grade 3
3.505800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.779000E-01
Grade 1-vs-Grade 3
5.705200E-01
Grade 1-vs-Grade 4
1.215780E-01
Grade 2-vs-Grade 3
9.031400E-01
Grade 2-vs-Grade 4
3.053200E-01
Grade 3-vs-Grade 4
3.505800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.529400E-01
Normal-vs-NonDiabetic
5.163200E-01
Diabetic-vs-NonDiabetic
7.384100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.982200E-01
Normal-vs-NoPancreatitis
5.564200E-01
Pancreatitis-vs-NoPancreatitis
8.773000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.625600E-01
Normal-vs-N1
3.378800E-01
N0-vs-N1
3.679800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.401200E-01
Normal-vs-TP53-NonMutant
4.570600E-01
TP53-Mutant-vs-TP53-NonMutant
5.509000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
